The present invention provides nucleic acid and amino acid sequence of the
novel I-1 and I-2 polypeptides, which are associated with human
inflammatory bowel disease (IBD). Methods of diagnosing and treating
inflammatory bowel disease using the IBD-associated I-1 and I-2 antigens
also are provided.
